Complete Genomics Turns Down Competing Acquisition Offer Citing Antitrust Worries | GenomeWeb

NEW YORK (GenomeWeb News) – Complete Genomics last week turned down a higher bid from an unidentified company after determining that the unsolicited proposal potentially may not meet regulatory approval, the Mountain View, Calif.-based firm disclosed in a document filed with the US Securities and Exchange Commission today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.